Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Net Income towards Common Stockholders Growth (1y) (2012 - 2026)

Analysis

Emergent BioSolutions (EBS) Net Income towards Common Stockholders Growth (1y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn -0.05%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 284.27%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -130.19%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn -19.23%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -108.13%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 152.55%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -91.06%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 151.28%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -1,401.67%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,401.67%
Mar 31, 2026 -90.00%
Dec 31, 2025 -74.44%
Sep 30, 2025 -55.40%
Jun 30, 2025 95.76%
Mar 31, 2025 655.56%
Dec 31, 2024 36.77%
Sep 30, 2024 143.58%
Jun 30, 2024 -8.30%
Mar 31, 2024 104.83%
Dec 31, 2023 26.12%
Sep 30, 2023 -202.41%
Jun 30, 2023 -363.48%
Mar 31, 2023 -4,932.43%
Dec 31, 2022 -137.66%
Sep 30, 2022 -166.36%
Jun 30, 2022 -1,326.09%
Mar 31, 2022 -105.31%
Dec 31, 2021 -4.41%
Sep 30, 2021 -182.78%
API Access

Emergent BioSolutions Net Income towards Common Stockholders Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders-growth-1y&ticker=EBS&period=max&api_key=YOUR_API_KEY